Stock
Ownership of a fraction of a corporation and the right to claim a share of the corporation's assets and profits equal to the amount of stock owned
US listed security
Listed on NASDAQ
US headquartered
Headquartered in Foster City, California, United States
Gilead Sciences, Inc.
$63.33
GILD
After Hours:
$63.30
(-0.047%)-$0.03
Closed: Jan 15, 7:59:47 PM GMT-5 · USD · NASDAQ · Disclaimer

In the news

Financial performance
(USD)Q3 2020Year/year change
Revenue
6.58B17.36%
Net income
360.00M130.90%
Diluted EPS0.29131.52%
Net profit margin5.47%126.31%
Operating income3.17B27.54%
Net change in cash6.14B447.68%
Cash on hand12.89B36.01%
Cost of revenue1.14B10.24%
About
Gilead Sciences, Inc., is an American biopharmaceutical company headquartered in Foster City, California, that focuses on researching and developing antiviral drugs used in the treatment of HIV, hepatitis B, hepatitis C, and influenza, including Harvoni and Sovaldi. Gilead is a member of the NASDAQ Biotechnology Index and the S&P 500. Wikipedia
Founded
Jun 22, 1987
Website
Employees
11,800

Key stats

Previous close
The last closing price
$62.40
Day range
The difference between the high and low prices over the past day
$62.13 - $63.60
Year range
The difference between the high and low prices over the past 52 weeks
$56.56 - $85.97
Market cap
A valuation method that multiplies the price of a company's stock by the total number of outstanding shares.
79.39B USD
Volume
The average number of shares traded each day over the past 30 days
9.61M
P/E ratio
The ratio of current share price to trailing twelve month EPS that signals if the price is high or low compared to other stocks
65.81
Dividend yield
The ratio of annual dividend to current share price that estimates the dividend return of a stock
4.29%
CDP Climate Change Score
A score provided by CDP (formerly the Carbon Disclosure Project) that rates a company on its climate transparency and performance
Primary exchange
Listed exchange for this security
NASDAQ
About
Gilead Sciences, Inc., is an American biopharmaceutical company headquartered in Foster City, California, that focuses on researching and developing antiviral drugs used in the treatment of HIV, hepatitis B, hepatitis C, and influenza, including Harvoni and Sovaldi. Gilead is a member of the NASDAQ Biotechnology Index and the S&P 500. Wikipedia
Founded
Jun 22, 1987
Website
Employees
11,800

Discover more

You may be interested in
This list is generated from recent searches, followed securities, and other activity. Learn more

All data and information is provided “as is” for personal informational purposes only, and is not intended to be financial advice nor is it for trading purposes or investment, tax, legal, accounting or other advice. Google is not an investment adviser nor is it a financial adviser and expresses no view, recommendation or opinion with respect to any of the companies included in this list or any securities issued by those companies. Please consult your broker or financial representative to verify pricing before executing any trades. Learn more

People also search for

Search
Clear search
Close search
Google apps
Main menu